Apremilast Spirig HC 10 mg / 20 mg / 30 mg, Filmtabletten

7680695550030 CH-69555 Filmtabletten
Apremilast Spirig HC 10 mg / 20 mg / 30 mg, Filmtabletten
Apremilast Spirig HC 10 mg / 20 mg / 30 mg, Filmtabletten
Apremilast Spirig HC 10 mg / 20 mg / 30 mg, Filmtabletten
1 / 3
google

Article details

Package size
4 + 4 + 19
Selling units
4
Measure
Tablette(n)
Galenic form
Filmtabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
22/07/2025
Patient information leaflet
Français
22/07/2025
Patient information leaflet
Italien
22/07/2025
Summary of Product Characteristics
Allemand
22/07/2025
Summary of Product Characteristics
Français
22/07/2025
Summary of Product Characteristics
Italien
22/07/2025

Detailed composition

Substance Quantity Type Category
apremilastum
20.0 MG Substance Wirkstoff (Principe actif)
apremilastum
30.0 MG Substance Wirkstoff (Principe actif)
apremilastum
10.0 MG Substance Wirkstoff (Principe actif)
cellulosi pulvis
- Substance HNIDK
cellulosi pulvis
- Substance HNIDK
cellulosi pulvis
- Substance HNIDK
lactosum monohydricum
134.03 MG Substance HBESI
lactosum monohydricum
44.68 MG Substance HBESI
lactosum monohydricum
89.36 MG Substance HBESI
calcii carbonas
- Substance HNIDK
calcii carbonas
- Substance HNIDK
calcii carbonas
- Substance HNIDK
amylum pregelificatum
- Substance HNIDK
amylum pregelificatum
- Substance HNIDK
amylum pregelificatum
- Substance HNIDK
crospovidonum
- Substance HNIDK
crospovidonum
- Substance HNIDK
crospovidonum
- Substance HNIDK
natrii stearylis fumaras
- Substance HNIDK
natrii stearylis fumaras
- Substance HNIDK
natrii stearylis fumaras
- Substance HNIDK
natrium
0.17 MG Substance HBESI
natrium
0.08 MG Substance HBESI
natrium
0.25 MG Substance HBESI
hypromellosum
- Substance HNIDK
hypromellosum
- Substance HNIDK
hypromellosum
- Substance HNIDK
E 171
- Substance FNIDK
E 171
- Substance FNIDK
E 171
- Substance FNIDK
macrogolum 4000
- Substance HNIDK
macrogolum 4000
- Substance HNIDK
macrogolum 4000
- Substance HNIDK
E 172 (flavum)
- Substance FTODK
E 172 (rubrum)
- Substance FTODK
E 172 (flavum)
- Substance FTODK
E 172 (rubrum)
- Substance FTODK
E 172 (rubrum)
- Substance FTODK
E 172 (nigrum)
- Substance FTODK

Reimbursement information

Public price
CHF 161.60
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/08/2025

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
69555
Drug name
Apremilast Spirig HC, Filmtabletten
Galenic form
FILM
ATC Code
L04AA32
Authorization status
Z
Dispensing category
B
First authorization
22/07/2025
Authorization expiration date
21/07/2030
IT Number
07.15.0.
Domain
Human medicine
Field of application
Aktive Psoriasis-Arthritis und mittelschwere bis schwere Plaque-Psoriasis

Package details

Description (FR)
APRÉMILAST SPIRIG HC cpr pell 10/20/30 mg 27 pce
Description (DE)
APREMILAST SPIRIG HC Filmtabl 10/20/30 mg 27 Stk
Market launch
22/07/2025
Narcotic (BTM)
No

Original drug

Otezla, Filmtabletten
GTIN: 7680653460036
CHF 334.85
View original

Other package sizes (2)

APRÉMILAST SPIRIG HC cpr pell 30 mg 56 pce
56 TABL
GTIN: 7680695550016
View
APRÉMILAST SPIRIG HC cpr pell 30 mg 168 pce
168 TABL
GTIN: 7680695550023
View
Buy us a coffee Explore the data